Background: Evaluation of lung nodules is a long standing clinical problem. Despite advances in diagnostics, many nodules are still resected that are benign. Although certain imaging characteristic can distinguish benign from malignant lung nodules on CT and PET/CT, overlap exists. Our purpose is to understand the benign resection rate with use of PET and PET/CT, and to review the patient and imaging characteristics of benign resected nodules in the PET-PET/ CT era. Method: We reviewed all 557 surgically resected lung nodules from 2001-2012. Patient demographics, smoking and cancer history, diagnostic tests prior to surgery, and pathology results were collected. All preoperative CT examinations were reviewed for nodule location, size, shape, border and attenuation, and PET/CTs for FDG-avidity. Result: Of 557 resected nodules in 541 patients, 39 nodules in 38 patients were benign (15 females, 23 male) for a benign resection rate of 7% (39/557). There was no significant difference between benign and malignant groups across sex, race, nodule size or attenuation. Patients with benign nodules were younger (mean age 59 vs. 65 years in the malignant group; p¼0.005). 75% of patients with benign nodules were smokers versus 80% in the malignant group (p¼0.04). In the benign nodule group, 14 patients (36%) had a cancer history. Benign pathology results were: 15 granuloma, 6 chronic inflammation, 5 hamartoma, 5 abscesses, 2 inflammatory pseudotumor, 2 organizing pneumonia and 1 case each of bronchogenic cyst, fibrous tumor, lipoid pneumonia and lymphoepithelioma. 62% of were in the right lung, and 46% were in an upper lobe. Nodule size was 10-95 mm (mean 29). CT nodule morphology was round/ovoid in 16, and triangular/angular in 3. Nodule border was lobulated in 4, smooth in 7 and spiculated in 8. Cavitation was present in 4 nodules, 14 were exclusively soft tissue attenuation and one contained fat. By attenuation, 18 were solid, and 1 was non solid (ground glass). Of the 18/38 (47%) patients who underwent preoperative PET/CT scan, nodule FDG uptake was: 5 intense, 10 mild, 3 none. Conclusion: Our benign resection rate for lung nodules is 7%. While in many cases the imaging characteristics of surgically proven benign lung nodules and their clinical management are appropriate, following clinical guidelines for nodule management may further reduce the benign resection rate. The use of PET/CT and follow up low dose chest CT for PET/CT negative or mild uptake lesions to confirm nodule stability over time is a pathway for management that requires reinforcement.
Background: Lung cancer remains the leading cause of mortality from malignancy in the United States despite significant advances. With the recent validation of low dose helix computed tomography (LD-CT) as a screening modality, there have been an increased number of diagnosed peripheral lung nodules that require evaluation. Electromagnetic navigation bronchoscopy (ENB) has emerged in recent years as a novel diagnostic modality that is purported to be equivalent to CT transthoracic needle aspiration (CT-TTNA) in diagnostic yield with a superior safety profile. We set out to evaluate the diagnostic yield and the number of adverse events of ENBs performed at the Brooklyn Veterans Affairs Hospital. Method: A retrospective chart review was done of ENB cases performed from 2012 until present. 45 cases were identified and chart review done to identify nodule size. location, distance to the pleura, PET-CT standardized uptake value (SUV), pathological yield, and clinical course following procedure. Two cases were excluded due to patients having been diagnosed with malignancy prior to ENB, thus 43 cases were included for final analysis. Result: 12 patients were identified with false negative biopsies (negative biopsy from ENB with subsequent positive pathologic diagnosis from either repeat ENB or surgical biopsy). 14 patients were found with disease, thus sensitivity of this test was calculated at 58.3%. 19 patients were found to have positive initial biopsies, thus negative predictive value (NPV) was calculated at 68.5%. There was an incidence of .04% of pneumothoraxes in our patient population whereas the incidence of pneumothorax following CT-TTA is reported to be approximately 20%. Conclusion:
We demonstrated that ENB in our institution is not as sensitive a modality in ruling out malignancy as previously described. While this raises the question of the clinical utility of ENB as a diagnostic tool, it still remains significantly safer than CT-TTNA in the evaluation of peripheral lung nodules. Background: Lung cancers associated with emphysematous bullae (EB) comprise approximately 5% of all primary lung cancers, but the clinicopathological characteristics remain unclear. This study aims to investigate the clinicopathological characteristics and postoperative prognosis of lung cancers associated with EB. Method: From 2008 through 2012, consecutive 517 patients who underwent complete surgical resection for primary lung cancer at our institution, were retrospectively reviewed. Lung cancer associated with EB was defined as lung cancer adjoining emphysematous airspace >1cm, without lung parenchyma, on preoperative thin-slice computed tomography scans. Among the 517 patients, 35 (6.8%) had lung cancers associated with EB (EB group). Their clinicopathological features and prognosis were retrospectively compared with those in the patients having lung cancer not associated with EB (non-EB group). Result: The median follow-up duration was 42 months (range, 2-85 months). The median age of EB group was 70 (39-79) years, while that for non-EB group was younger 59 (33-91) years (p ¼ 0.07). The EB group included 
